Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds

PRRT

  • Imaging Pathway of a Pediatric Patient with Succinate Dehydrogenase B-Deficient Paraganglioma
    You have access
    Imaging Pathway of a Pediatric Patient with Succinate Dehydrogenase B-Deficient Paraganglioma
    Stephen Edmonds, Jennifer Davidson, Rosanne Joseph and Madhusudan Vyas
    Journal of Nuclear Medicine Technology December 1, 2023, 51 (4) 318-322; DOI: https://doi.org/10.2967/jnmt.123.265655
  • Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review
    You have access
    Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review
    Emran Askari, Soroush Zarehparvar Moghadam, Damian Wild, Ebrahim Delpassand, Sergio Baldari, Bernhard Nilica, Philipp E. Hartrampf, Grace Kong, Chiara Maria Grana, Martin Alexander Walter, Francesca Capoccetti, Pashtoon Murtaza Kasi and Jonathan Strosberg
    Journal of Nuclear Medicine Technology March 1, 2023, 51 (1) 22-25; DOI: https://doi.org/10.2967/jnmt.122.264904
  • Improving <sup>90</sup>Y PET Scan Image Quality Through Optimized Reconstruction Algorithms
    You have access
    Improving 90Y PET Scan Image Quality Through Optimized Reconstruction Algorithms
    Pei Ing Ngam, Eelin Tan, Gabriel Lim and Sean Xuexian Yan
    Journal of Nuclear Medicine Technology March 1, 2023, 51 (1) 26-31; DOI: https://doi.org/10.2967/jnmt.122.264439
  • You have access
    Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
    Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa and Stephen A. Graves
    Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 195-202; DOI: https://doi.org/10.2967/jnmt.122.263813
  • You have access
    Technical Aspects and Administration Methods of 177Lu-DOTATATE for Nuclear Medicine Technologists
    Audrey B. Davis, Melanie H. Pietryka and Susan Passalaqua
    Journal of Nuclear Medicine Technology December 1, 2019, 47 (4) 288-291; DOI: https://doi.org/10.2967/jnmt.118.221846
  • You have access
    Bilateral Orbital Soft-Tissue Metastases from Renal Neuroendocrine Tumor: Successful Theranostic Application of 68Ga/177Lu-DOTATATE with Improvement of Vision
    Rahul V. Parghane and Sandip Basu
    Journal of Nuclear Medicine Technology June 1, 2019, 47 (2) 171-172; DOI: https://doi.org/10.2967/jnmt.118.217455
  • You have access
    Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?
    Sandip Basu and Rohit Ranade
    Journal of Nuclear Medicine Technology June 1, 2016, 44 (2) 85-87; DOI: https://doi.org/10.2967/jnmt.115.163527
SNMMI

© 2025 SNMMI

Powered by HighWire